Leqi Shen. HR-Positive Breast Cancer and New Potentially Synergistic Approaches with CDK Inhibition of the Retinoblastoma Protein and CAR T-Cell Immunotherapy. JIMR [nternet]. 2023 Nov. 10 [cited 2025 Apr. 30];2(11):24-7. vailable from: https://www.paradigmpress.org/jimr/article/view/860